StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > $0,43 = $0,05 pre consolidation

<< Previous

Bullboard Posts

Next >>

Comment by 4real4everon Aug 01, 2021 7:03pm

114 Views

Post# 33638856

RE:RE:RE:RE:$0,43 = $0,05 pre consolidation

$3,50 in two months!! LMAO You're so funny or naive. Don't bet to much on this

TELL ME ANYTHING AND I'LL BELIEVE IT! - Buddy the Elf | Meme Generator

capebretongirl wrote: The fact is that if this stock was sitting at $3.50 in two months - you would then be posting that it would never hit $5.00!!

4real4ever wrote: There is no IF here. Just to look to hear or see the facts.

capebretongirl wrote: IF thats true then why are you doing just that??

4real4ever wrote: No one need to bash SZLS, they do it themselves very well

Look the 5 years chart
Listen all the latest CC
Look all the past NR
Look all the latest PP

ESPECIALLY THE ARISTOTLE LAUNCH (their one and final star)